GLP-1 agonists and lean body mass loss part 2 w/ Dr. Grant Tinsley

Drs. Karl and Spencer bring back Dr. Grant Tinsley, a body composition researcher, to go over the GLP-1 data (semaglutide and tirzepatide) in terms of lean body mass loss. Learn: - How much lean body mass is lost in these trials - How body composition is measured - How is muscle loss assessed - Should you be worried if you're taking a GLP-1 agonist Read Dr. Tinsley's blog Become a Sequence patient (evaluation for GLP-1 agonist)